1 Definition of diabetic renal disease in insulin-dependent diabetes mellitus based on renal function tests --;2 Albuminuria and renal disease in NIDDM-patients --;3 Familial factors in diabetic nephropathy --;4 Hypertension, cardiovascular disease, diabetes mellitus, and diabetic nephropathy: role of insulin resistance --;5 Diabetes, hypertension, and kidney disease in the Pima Indians compared with other populations --;6 Economic evaluations of strategies for preventing renal disease in non-insulin dependent diabetes mellitus --;7 Incidence of nephropathy in insulin-dependent diabetes mellitus as related to mortality and cost-benefit of early intervention --;8 Measurement of albumin and other urinary proteins in low concentration in diabetes mellitus: techniques and clinical significance --;9 Office tests for microalbuminuria --;10 Risk factor for progression of microalbuminuria in relatively young NIDDM-patients --;11 The clinical course of renal disease in Caucasian NIDDM-patients --;12 Von Willebrand factor and the development of renal and vascular complications in diabetes --;13 Smoking and diabetic nephropathy --;14 Light microscopy of diabetic glomerulopathy: the classic lesion --;15 Haematuria and diabetic nephropathy --;16 Glomerular ultrastructural changes in microalbuminuric IDDM-patients --;17 Understanding of diabetic nephropathy from kidney and pancreas transplantation --;18 Sodium-hydrogen antiport, cell function and susceptibility to diabetic nephropathy --;19 Biochemical aspects of diabetic nephropathy --;20 The Steno hypothesis and glomerular basement membrane biochemistry in diabetic nephropathy --;21 Volume homeostasis and blood pressure in diabetic states --;22 Pathogenesis of diabetic glomerulopathy: the role of glomerular hemodynamic factors --;23 Roles of growth factors in diabetic kidney disease --;24 Blood pressure elevation in diabetes: results from 24-h ambulatory blood pressure recordings in diabetes --;25 Insulin and blood pressure --;26 Cation transport, hypertension and diabetic nephropathy --;27 Microalbuminuria in young patients with type 1 diabetes --;28 Early renal hyperfunction and hypertrophy in IDDM patients including comments on early intervention --;29 The concept of incipient diabetic nephropathy and effect of early antihypertensive intervention --;30 Comparative study of the effect of Ace-inhibitors and other antihypertensive agents on proteinuria in diabetic patients --;31 Clinical trials in overt diabetic nephropathy --;32 Antihypertensive treatment in NIDDM, with special reference to abnormal albuminuria --;33 The course of incipient and overt diabetic nephropathy: the perspective of more optimal insulin treatment --;34 Meta-analysis of the effect of intensive therapy on nephropathy in type I diabetes mellitus --;35 Non-glycaemic intervention in diabetic nephropathy: the role of dietary protein intake --;36 Microalbuminuria and diabetic pregnancy --;37 Diabetic nephropathy and pregnancy --;38 Urinary tract infection and diabetes: diagnosis and treatment --;39 Acute renal failure in diabetics --;40 Contrast media-induced nephropathy in diabetic renal disease --;41 Renal papillary necrosis in diabetic patients --;42 Problems related to the start of renal replacement therapy in diabetic patients --;43 Evolution worldwide of the treatment of patients with advanced diabetic nephropathy by renal replacement therapy --;44 Haemodialysis in type 1 and type 2 diabetic patients with end stage renal failure --;45 Continuous ambulatory peritoneal dialysis in uremic diabetics --;46 Simultaneous pancreas and kidney transplantation: indication and results --;47 Renal transplantation for diabetic nephropathy --;St Vincent Declaration, 1994: Guidelines for the prevention of diabetic renal failure.
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
Diabetic nephropathy is a worldwide problem, but it is more clearly defined in Europe and North America where facilities for the diagnosis and treatment of diabetes and its complications are readily available.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Cardiology.
موضوع مستند نشده
Diabetes.
موضوع مستند نشده
Medicine.
رده بندی کنگره
شماره رده
RC918
.
D53
نشانه اثر
E358
1994
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )